Music Induced Modulation of Pressure Pain Sensitivity and Affective Valence, Comparing Silence and Self-Selected Levantine Music
1 other identifier
interventional
32
1 country
1
Brief Summary
Pain perception is strongly influenced by emotional state, and music has emerged as a promising non-pharmacological tool for pain modulation through its effects on affective state, attention, and autonomic physiology. Despite growing evidence supporting music-induced analgesia, most studies have focused on Western populations and music genres. Levantine music, rooted in the maqam system-melodic modes with deeply embedded emotional associations- remains largely unexplored in this context. Furthermore, evidence on the effects of music on healthy individuals is limited. Objective: This pilot study aims to examine the effect of self-selected Levantine music on pressure pain threshold (PPT) and affective valence compared to silence in healthy Lebanese university students, and to establish feasibility for a future full-scale randomized controlled trial. Design: Randomized, crossover, counterbalanced pilot study with assessor blinding. Approved by the Antonine University Ethics Committee. Reported following CONSORT guidelines. Participants: 12 healthy Lebanese adults (aged 18-25), divided into 2 groups of 6. Inclusion requires no chronic pain, no hearing impairment, and no current analgesic use. Participants are excluded for neurological, cardiovascular, metabolic, or psychiatric conditions, recent injury at testing sites, or hypertension (\>140/90 mmHg). Procedure: Both groups were assessed at baseline while seated, with PPT, blood pressure, heart rate, and affective valence (SAM) all recorded before any auditory condition began. Participants were then fitted with the Sony WH-1000XM6 noise-cancelling headphones. Group 1 starts with silence, then listens to self-selected Levantine music. Group 2 does the reverse. A 15-minute rest period separates the two conditions to avoid carryover effects. All sessions take place at the same time of day, in a standardized environment, with noise controlled through the same headphones. Outcome Measures:
- Primary: PPT, measured using a Wagner FPX 50 digital algometer (kg/cm²) at two sites on the non-dominant side: the upper trapezius and the lateral calf. Pressure is applied at 1 kg/s; the mean of four readings is used. A ≥10% increase in PPT from baseline defines a responder. Meaningful change is evaluated against the Minimal Detectable Change (MDC95).
- Primary: NPRS: An 11-point numeric pain rating scale (0 = no pain, 10 = worst possible pain) administered during each PPT measurement.
- Secondary: SAM: The Self-Assessment Manikin, a non-verbal pictorial scale measuring emotional valence, arousal, and dominance (Cronbach's α = 0.83), completed at baseline and after each condition.
- Secondary: BP \& HR: Blood pressure and heart rate measured via digital sphygmomanometer and oximeter as markers of autonomic cardiovascular response. Statistical Analysis: Descriptive statistics (mean ± SD) will be reported for all outcomes. Primary inferential analysis will use a repeated-measures ANOVA or linear mixed-effects model. Exploratory mediation analysis will assess whether changes in valence and/or arousal mediate the relationship between auditory condition and PPT change. Pilot findings will inform power calculations for the full-scale trial. Hypotheses: Self-selected Levantine music is expected to produce a greater increase in PPT than silence, with positive affective valence and optimal arousal hypothesized as partial mediators of this effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2026
CompletedFirst Submitted
Initial submission to the registry
March 17, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2026
CompletedMarch 27, 2026
March 1, 2026
2 months
March 17, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pressure Pain Sensitivity
PPT was assessed as the primary outcome to quantify participants' sensitivity to mechanical pain. PPT measurements were obtained using a Wagner digital algometer at standardized musculoskeletal sites. Participants were instructed to indicate the point at which applied pressure first became painful, and the force (in kilograms) was recorded. Each site was measured twice, with the mean value used for analysis. PPT was measured under both experimental conditions-silence and self-selected Levantine music-to evaluate the modulatory effects of music on pressure pain sensitivity. Changes in PPT between conditions were used to determine the analgesic or pain-modulating effect of the music intervention, with higher PPT values indicating reduced pain sensitivity. This method is consistent with prior research demonstrating that PPT is a reliable and valid marker of musculoskeletal pain sensitivity.
Up to 80 minutes of assesing the participants at the 3 interventions
Secondary Outcomes (3)
Affective Valence
Up to 80 minutes to test the valence change with the 3 interventions
Blood Pressure
During the 3 intervention session (approximately 80 minutes)
Heart Rate
Up to 80 minutes during the 3 intervention conditions
Study Arms (2)
Group one: Baseline , Silenced, Levantine Music
OTHERFirst assessed at baseline; the participant was seated and only standard formal interaction occurred. The participant was then fitted with Sony headphones. A 15-minute rest interval was implemented between sessions to minimize potential carryover effects (Becker et al., 2024). They will then be first exposed to the silence condition followed by the self-selected Levantine music.
Group Two: Baseline, Levantine Music, Silenced
EXPERIMENTALFirst assessed at baseline; the participant was seated and only standard formal interaction occurred. The participant was then fitted with Sony headphones. A 15-minute rest interval was implemented between sessions to minimize potential carryover effects (Becker et al., 2024). They were then first exposed to the self-selected Levantine Music condition followed by the silenced condition.
Interventions
Both groups were assessed at baseline; the participant was seated and only standard formal interaction occurred. The participant was then fitted with Sony headphones. A 15-minute rest interval was implemented between sessions to minimize potential carryover effects (Becker et al., 2024). If participants were allocated to Group 1, they were first exposed to the silence condition followed by the self-selected Levantine music. If allocated to Group 2, they were exposed to the Levantine music condition first, followed by the silence condition. This sequence was implemented to examine whether the order of conditions had a significant effect on pain
Eligibility Criteria
You may qualify if:
- Healthy Lebanese adults aged 18 to 25 years
- No chronic pain
- No hearing impairment
- No current use of analgesic medication
You may not qualify if:
- Neurological disorders
- Recent injury at PPT assessment sites
- Regular use of medication
- Pregnancy
- Severe allergic reactions
- Systemic disease
- Neurological disease
- Metabolic disease
- Cardiovascular disease
- Chronic pain
- Ongoing psychiatric or psychological treatment
- Hypertension (\>140/90 mmHg)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- charbel najemlead
Study Sites (1)
Antonine University
Baabda, Baabda, Lebanon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Statistision
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Instuctor and proffesor at the Antonine University
Study Record Dates
First Submitted
March 17, 2026
First Posted
March 27, 2026
Study Start
February 12, 2026
Primary Completion
April 5, 2026
Study Completion
April 24, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Participants privacy and confedenciatility will be preserved, participants name will not be collected, only a eligibility data will be obtained, and outcome measures.